Xie Weijia, Yuan Shuai, Sun Zhifu, Li Yafei
Department of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People's Republic of China.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Epigenomics. 2016 Sep;8(9):1275-87. doi: 10.2217/epi-2016-0036. Epub 2016 Sep 2.
Better understanding and management of lung cancer are needed. Although much has been learned from known protein coding genes, long noncoding RNAs (lncRNAs), a relatively new and fast evolving large family of transcripts, have recently generated much attention for new discoveries. LncRNAs play critical regulatory functions and are emerging as new players in tumorigenesis and phenotypic determinators of lung cancer. In this review, we highlight the latest development of lncRNAs, including circular RNAs in lung cancer. We start with well-characterized lncRNAs and circular RNAs as an oncogene or tumor suppressor and then extend our discussion on the impact of SNPs in lncRNA on its functions and lung cancer risk and the clinical applications of lncRNAs as biomarkers and therapeutic targets.
需要更好地理解和管理肺癌。尽管从已知的蛋白质编码基因中学到了很多,但长链非编码RNA(lncRNAs)作为一个相对较新且快速发展的转录本大家族,最近因其新发现而备受关注。lncRNAs发挥着关键的调节功能,并正在成为肺癌肿瘤发生和表型决定因素中的新角色。在本综述中,我们重点介绍了lncRNAs的最新进展,包括肺癌中的环状RNA。我们首先从已被充分表征的作为癌基因或肿瘤抑制因子的lncRNAs和环状RNA开始,然后扩展讨论lncRNA中的单核苷酸多态性对其功能和肺癌风险的影响,以及lncRNAs作为生物标志物和治疗靶点的临床应用。